| Title : Suspected adverse drug reactions of the type 2 antidiabetic drug class dipeptidyl-peptidase IV inhibitors (DPP4i): Can polypharmacology help explain? - Jones_2022_Pharmacol.Res.Perspect_10_e01029 |
| Author(s) : Jones L , Jones AM |
| Ref : Pharmacol Res Perspect , 10 :e01029 , 2022 |
| Abstract : Jones_2022_Pharmacol.Res.Perspect_10_e01029 |
| ESTHER : Jones_2022_Pharmacol.Res.Perspect_10_e01029 |
| PubMedSearch : Jones_2022_Pharmacol.Res.Perspect_10_e01029 |
| PubMedID: 36468400 |
Jones L, Jones AM (2022)
Suspected adverse drug reactions of the type 2 antidiabetic drug class dipeptidyl-peptidase IV inhibitors (DPP4i): Can polypharmacology help explain?
Pharmacol Res Perspect
10 :e01029
Jones L, Jones AM (2022)
Pharmacol Res Perspect
10 :e01029